Back to top

stock-price-change: Archive

Zacks Equity Research

Primoris Services (PRIM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Primoris Services (PRIM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRIMNegative Net Change MTZNegative Net Change

Zacks Equity Research

Procore Technologies (PCOR) Earnings Expected to Grow: Should You Buy?

Procore Technologies (PCOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PCORNegative Net Change

Zacks Equity Research

Par Petroleum (PARR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Par Petroleum (PARR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PARRNegative Net Change

Zacks Equity Research

Navigator Holdings (NVGS) Reports Next Week: Wall Street Expects Earnings Growth

Navigator Holdings (NVGS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NVGSNegative Net Change

Zacks Equity Research

Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Mirum Pharmaceuticals (MIRM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MIRMPositive Net Change TGTXNegative Net Change

Zacks Equity Research

Will Madrigal (MDGL) Report Negative Earnings Next Week? What You Should Know

Madrigal (MDGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MDGLNegative Net Change

Zacks Equity Research

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Rhythm Pharmaceuticals (RYTM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RYTMNegative Net Change AXSMNegative Net Change

Zacks Equity Research

Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Revvity (RVTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RVTYNegative Net Change

Zacks Equity Research

Earnings Preview: Revolve Group (RVLV) Q3 Earnings Expected to Decline

Revolve Group (RVLV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RVLVNegative Net Change CROXNegative Net Change

Zacks Equity Research

Ultragenyx (RARE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Ultragenyx (RARE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RARENegative Net Change JAZZNegative Net Change